Positron Income After Taxes 2010-2024 | POSC
Positron income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
| Positron Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $-2 |
| 2023 | $-2 |
| 2022 | $-3 |
| 2021 | $-1 |
| 2020 | $0 |
| 2019 | $0 |
| 2014 | $-3 |
| 2013 | $-7 |
| 2012 | $-8 |
| 2011 | $-6 |
| 2010 | $-11 |
| 2009 | $-6 |
| Positron Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-1 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $-1 |
| 2023-12-31 | $0 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $-1 |
| 2022-09-30 | $-1 |
| 2022-06-30 | $0 |
| 2022-03-31 | $-1 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $-1 |
| 2014-12-31 | $0 |
| 2014-09-30 | $-1 |
| 2014-06-30 | $0 |
| 2014-03-31 | $-1 |
| 2013-12-31 | $-3 |
| 2013-09-30 | $-1 |
| 2013-06-30 | $-1 |
| 2013-03-31 | $-1 |
| 2012-12-31 | $-2 |
| 2012-09-30 | $-2 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-3 |
| 2011-12-31 | $-1 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $-3 |
| 2011-03-31 | $-1 |
| 2010-12-31 | $-2 |
| 2010-09-30 | $0 |
| 2010-06-30 | $-6 |
| 2010-03-31 | $-3 |
| 2009-12-31 | $-3 |
| 2009-09-30 | $-1 |
| 2009-06-30 | $-1 |
| 2009-03-31 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.050B | $0.001B |
| Positron Corporation is engaged in designing, manufacturing, marketing and supporting advanced medical imaging devices utilizing positron emissiontomography technology under the trade name POSICAM systems. POSICAM systems incorporate patented and proprietary technology for the diagnosis and treatment of patients in the areas of oncology, cardiology and neurology. | |||